Shortage Of Radioisotopes Raises Concerns

Concerns have been raised in Northern Ireland over a significant UK shortage of radioisotopes which may disrupt patient care in the upcoming weeks.

Radioisotopes are mainly used for diagnosing cancers, including prostate and breast cancer, as well as heart issues.

The shortage is due to a temporary reduction in the production of molybdenum-99 which is used to generate technetium-99m. The radioisotope technetium-99m is used safely for diagnostics within Health and Social Care.

Health Minister Mike Nesbitt released an update regarding the shortage, stating: "Despite efforts by my Department, working in partnership with the Department of Health and Social Care (DHSC) and the other devolved administrations to limit the negative impacts of this shortage, it is expected that there will be delays to patient access to services relying on the impacted radioisotopes, potentially including cancellations."

He continued: "The supply chains for medicines including radioisotopes are complex, global, and highly regulated. While we can’t always prevent supply issues from occurring, we have a range of well-established processes and tools to manage them when they arise and mitigate risks to patients.

"The priority during this period of supply disruption is to minimise the impact on patients as much as possible. My Department is working with DHSC, devolved administrations, suppliers and clinical experts to support the allocation of deliveries and ensure there is equitable and fair access across the UK to the constrained supply of stock that is available." Meanwhile, SDLP Opposition Health Spokesperson Colin McGrath has expressed his concern for patients following the shortage.

"I want to express my empathy for those patients and families who are facing uncertainty and distress during this time," he said.

"It is worrying to learn of the potential delays and cancellations that may arise as a result of this shortage of radioisotopes.

"While I welcome the Minister's efforts to coordinate with the Department of Health and Social Care in London and other devolved administrations to manage this issue, it is imperative that we hold the government accountable for ensuring that patient care is not compromised.

"That the UK relies on limited international sources for essential medical supplies seems untenable. We must have a more robust strategy to secure a reliable supply of critical medical resources here.

"I would also urge the Minister and departmental officials to ensure that all patients receive clear communication regarding their treatment options.

"It is vital that medical staff engage directly with patients to discuss potential alternatives, such as different scans or procedures, to mitigate anxiety and provide reassurance during this uncertain period.

"The Minister must remain open and transparent about ongoing efforts to resolve this situation and to ensure the well-being of patients above all else."

To read the Minister's full update on the shortage of Radioisotopes, click here.